Church & Dwight Co., Inc. (NYSE:CHD) Director Sells $1,203,505.60 in Stock

Church & Dwight Co., Inc. (NYSE:CHD) Director Arthur B. Winkleblack sold 11,590 shares of the business’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $103.84, for a total transaction of $1,203,505.60. Following the completion of the transaction, the director now owns 7,129 shares of the company’s stock, valued at approximately $740,275.36. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Church & Dwight Trading Up 1.1 %

Shares of CHD opened at $104.13 on Wednesday. The company has a current ratio of 1.62, a quick ratio of 1.09 and a debt-to-equity ratio of 0.53. Church & Dwight Co., Inc. has a 12-month low of $86.23 and a 12-month high of $110.31. The firm has a 50-day moving average price of $102.98 and a 200 day moving average price of $104.03. The firm has a market capitalization of $25.51 billion, a P/E ratio of 46.70, a P/E/G ratio of 3.78 and a beta of 0.55.

Church & Dwight (NYSE:CHD) last announced its quarterly earnings data on Friday, November 1st. The company reported $0.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.68 by $0.11. Church & Dwight had a net margin of 9.08% and a return on equity of 19.90%. The firm had revenue of $1.51 billion during the quarter, compared to analyst estimates of $1.50 billion. During the same quarter in the prior year, the firm posted $0.74 earnings per share. Church & Dwight’s quarterly revenue was up 3.8% on a year-over-year basis. Sell-side analysts forecast that Church & Dwight Co., Inc. will post 3.45 EPS for the current year.

Church & Dwight Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Investors of record on Friday, November 15th will be issued a $0.2838 dividend. This represents a $1.14 dividend on an annualized basis and a dividend yield of 1.09%. The ex-dividend date is Friday, November 15th. Church & Dwight’s dividend payout ratio is currently 50.67%.

Wall Street Analysts Forecast Growth

CHD has been the subject of a number of research analyst reports. JPMorgan Chase & Co. upped their price objective on shares of Church & Dwight from $98.00 to $99.00 and gave the stock an “underweight” rating in a research report on Monday. Piper Sandler initiated coverage on shares of Church & Dwight in a research report on Tuesday, September 24th. They set an “overweight” rating and a $120.00 price objective for the company. Evercore ISI reduced their price objective on shares of Church & Dwight from $110.00 to $101.00 and set an “in-line” rating for the company in a research report on Monday, August 5th. Stifel Nicolaus reduced their price objective on shares of Church & Dwight from $107.00 to $105.00 and set a “hold” rating for the company in a research report on Monday, August 5th. Finally, Morgan Stanley cut shares of Church & Dwight from an “overweight” rating to an “equal weight” rating and set a $110.00 price objective for the company. in a research report on Monday, September 9th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $108.05.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Capital International Investors boosted its stake in Church & Dwight by 1.0% during the first quarter. Capital International Investors now owns 9,097,575 shares of the company’s stock worth $948,968,000 after buying an additional 92,862 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Church & Dwight by 2.1% during the second quarter. Massachusetts Financial Services Co. MA now owns 7,586,482 shares of the company’s stock worth $786,566,000 after buying an additional 153,127 shares during the period. Allspring Global Investments Holdings LLC lifted its position in shares of Church & Dwight by 5.5% during the third quarter. Allspring Global Investments Holdings LLC now owns 3,358,179 shares of the company’s stock worth $351,668,000 after purchasing an additional 175,221 shares in the last quarter. ProShare Advisors LLC lifted its position in shares of Church & Dwight by 1.8% during the first quarter. ProShare Advisors LLC now owns 1,783,412 shares of the company’s stock worth $186,028,000 after purchasing an additional 31,145 shares in the last quarter. Finally, Millennium Management LLC lifted its position in shares of Church & Dwight by 1,617.3% during the second quarter. Millennium Management LLC now owns 1,292,854 shares of the company’s stock worth $134,043,000 after purchasing an additional 1,217,568 shares in the last quarter. Hedge funds and other institutional investors own 86.60% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.